Nancy U. Lin
Impact in
- Oncology top 0.1%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 194
- Cancer Treatment and Pharmacology 76
- HER2/EGFR in Cancer Research 69
- Lung Cancer Research Studies 45
-
- Brain Metastases and Treatment 115
- Advanced Breast Cancer Therapies 64
- Lung Cancer Treatments and Mutations 43
- Co-authors
- Eric P. Winer (154 shared papers)Ana C. Garrido-Castro (20 shared papers)Kornélia Polyák (4 shared papers)Jennifer R. Bellon (8 shared papers)Lalitha Shankar (6 shared papers)Elisabeth G.E. de Vries (6 shared papers)Janet Dancey (6 shared papers)F. Stephen Hodi (5 shared papers)
- Journals
- Journal of Clinical Oncology (94 papers)Cancer Research (42 papers)Breast Cancer Research and Treatment (30 papers)Clinical Cancer Research (15 papers)Neuro-Oncology (14 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Nancy U. Lin
358 papers receiving 17.6k citations
Nancy U. Lin's Hit Papers
Peers
Comparison fields: 5 of 163
- Oncology 8.1k
- Cancer Research 3.0k
- Pulmonary and Respiratory Medicine 6.4k
- Genetics 1.5k
- Radiology, Nuclear Medicine and Imaging 1.6k
Countries citing papers authored by Nancy U. Lin
This map shows the geographic impact of Nancy U. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy U. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy U. Lin more than expected).
Fields of papers citing papers by Nancy U. Lin
This network shows the impact of papers produced by Nancy U. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy U. Lin. The network helps show where Nancy U. Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy U. Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 383 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics Hit paper breakdown → | 2017 | 1580 |
| 2 | RECIST 1.1—Update and clarification: From the RECIST committee Hit paper breakdown → | 2016 | 1258 |
| 3 | Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment Hit paper breakdown → | 2019 | 1012 |
| 4 | Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer Hit paper breakdown → | 2008 | 557 |
| 5 | CNS Metastases in Breast Cancer Hit paper breakdown → | 2004 | 548 |
| 6 | Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study Hit paper breakdown → | 2017 | 520 |
| 7 | 2012 | 483 | |
| 8 | Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer Hit paper breakdown → | 2016 | 373 |
| 9 | 2008 | 354 | |
| 10 | 1997 | 326 | |
| 11 | 2007 | 310 | |
| 12 | 2014 | 290 | |
| 13 | 2014 | 259 | |
| 14 | 2020 | 256 | |
| 15 | 2011 | 244 | |
| 16 | 2017 | 231 | |
| 17 | 2016 | 229 | |
| 18 | Global challenges and policy solutions in breast cancer control Hit paper breakdown → | 2022 | 188 |
| 19 | 2016 | 184 | |
| 20 | STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer Hit paper breakdown → | 2022 | 181 |
About Nancy U. Lin
Nancy U. Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 383 papers that have together received 17.8k indexed citations. Recurring topics across this work include Brain Metastases and Treatment (115 papers), Cancer Treatment and Pharmacology (76 papers), Breast Cancer Treatment Studies (71 papers), HER2/EGFR in Cancer Research (69 papers), Advanced Breast Cancer Therapies (64 papers), Lung Cancer Research Studies (45 papers), Lung Cancer Treatments and Mutations (43 papers) and Cancer Genomics and Diagnostics (36 papers). The work is most often cited by research in Oncology (8.1k citations), Cancer Research (3.0k citations), Pulmonary and Respiratory Medicine (6.4k citations), Genetics (1.5k citations) and Radiology, Nuclear Medicine and Imaging (1.6k citations). Nancy U. Lin has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Eric P. Winer, Ana C. Garrido-Castro, Kornélia Polyák, Jennifer R. Bellon, Lalitha Shankar, Elisabeth G.E. de Vries, Janet Dancey, F. Stephen Hodi, Sumithra J. Mandrekar and Jan Bogaerts. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment, Clinical Cancer Research and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.